Oxis Turbohaler 6 (Formoterol Fumarate Dihydrate)

Formoterol fumarate dihydrate is a bronchodilator that acts on the airway smooth‑muscle pathway to improve airflow in chronic respiratory disease.

• Asthma: improves symptom control and reduces the frequency of exacerbations.
• Chronic obstructive pulmonary disease (COPD): enhances bronchodilation and supports maintenance therapy.
• Exercise‑induced bronchoconstriction: prevents airway narrowing during physical activity.

• Formoterol binds selectively to β2‑adrenergic receptors on airway smooth‑muscle cells, activating adenylate cyclase and increasing intracellular cyclic AMP. The rise in cAMP leads to relaxation of smooth‑muscle fibers, producing sustained bronchodilation and improved airflow during the respiratory cycle.

Formoterol may cause a range of adverse reactions, most of which are mild to moderate in severity.

Common Side Effects

• Tremor: mild, transient shaking of the hands or limbs.
• Headache: dull or throbbing discomfort, often resolving without intervention.
• Throat irritation: mild soreness or dryness after inhalation.
• Cough: brief episodes triggered by the inhaled powder.
• Palpitations: sensation of rapid or irregular heartbeat, usually transient.
• Nasal congestion: mild blockage or runny nose.

Serious or Rare Side Effects

• Paradoxical bronchospasm: sudden worsening of airway obstruction requiring immediate medical attention.
• Cardiac arrhythmias: irregular heart rhythms that may be life‑threatening.
• Hypokalemia: low blood potassium levels that can affect muscle function.
• Severe allergic reaction: rash, swelling, or difficulty breathing indicating anaphylaxis.

When using Formoterol, patients and clinicians should observe several safety measures.

• Assess baseline lung function: perform spirometry before initiating therapy.
• Monitor for cardiovascular effects: watch for tachycardia, palpitations, or hypertension.
• Avoid abrupt discontinuation: taper under medical supervision to prevent rebound bronchoconstriction.
• Use with a rescue inhaler: maintain a short‑acting bronchodilator for acute symptoms.
• Educate on inhaler technique: ensure correct use to maximize drug delivery and minimize oral deposition.
• Store at ambient temperature: keep below 25°C, in the original packaging, protected from moisture and direct sunlight.

Formoterol can interact with several drug classes, altering its safety profile or efficacy.

Major Interactions (Avoid)

• Non‑selective β‑blockers: may diminish bronchodilator response and precipitate bronchospasm.
• Monoamine oxidase inhibitors (MAOIs): increase the risk of cardiovascular side effects.
• Diuretics (especially loop diuretics): may exacerbate hypokalemia when combined with Formoterol.

Moderate Interactions (Monitor Closely)

• Other β2‑agonists: additive bronchodilator effect can raise the risk of tachycardia.
• Theophylline: may increase plasma concentrations of Formoterol.
• Anticholinergics: combined use may enhance bronchodilation but requires monitoring for dry mouth and urinary retention.